Enrolling Now
Study Information

Research evaluating new therapeutic options for Nonalcoholic Steatohepatitis (NASH), newly known as Metabolic Dysfunction-Associated Steatohepatitis (MASH), which involves severe liver inflammation and fat accumulation that can progress to fibrosis.

Basic Eligibility: Adult participants with biopsy-confirmed or highly suspected fatty liver disease and associated Stage 2 or 3 liver fibrosis.

Apply to Participate

If you are interested in participating in this study, please complete the following preliminary qualification form.

We will follow-up with you after we have received your submission.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

General Information

Name*

Preferences

Areas of Interest
Email Opt-In*
SMS/Text Opt-In*